🔎 Trials Near Me

Beranda › Kanker Kolorektal › Oregon › Portland

Uji klinis Kanker Kolorektal di Portland, OR

28 studi untuk Kanker Kolorektal mencari peserta di lokasi sekitar Portland (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Menerima peserta
  • Oregon Health & Science University (Knight Cancer Institute), Portland
Usia 65 hingga 82 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05612347

Family Communications After Genetic Testing

Menerima pesertaSukarelawan sehat diterima
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07143487

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • Oregon Health & Science University (OHSU), Portland
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Menerima pesertaFase 2
  • Oregon Health and Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Menerima pesertaFase 1
  • Exelixis Clinical Site #51, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Menerima pesertaFase 1
  • ALX Center 6, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Menerima pesertaFase 1
  • Research Site, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05877599

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • Kaiser Permanente Interstate Medical Office Central, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Menerima pesertaFase 3
  • Oregon Health And Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06750094

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Menerima pesertaFase 1
  • Research Site, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06218914

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Menerima pesertaFase 3
  • Oregon Health And Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Menerima pesertaFase 3
  • Oregon Health and Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05863195

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Menerima pesertaFase 2
  • Research Site, Portland
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Oregon Health and Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

A Study of MGC026 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • Providence Cancer Institute, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Oregon Health & Science University, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • Investigative Site #121, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06974110

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • Providence Cancer Institute Franz Clinic, Portland
  • Providence Portland Medical Center, Portland
  • Providence Oncology and Hematology Care Clinic - Westside, Portland
  • dan 5 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05253651

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Menerima pesertaFase 2
  • OHSU Knight Cancer Institute, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT05705492

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Menerima pesertaFase 2
  • Northwest Cancer Specialists - Compass, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT07011576

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Menerima pesertaFase 3Sukarelawan sehat diterima
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Mar 2026 · NCT07018869

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Kaiser Permanente Northwest, Portland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Oregon Health Sciences University, Portland
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Menerima pesertaStudi observasional
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jan 2026 · NCT06073431

Evaluation of Gixam's Performance in a FIT Negative Population

Menerima pesertaFase 2
  • The Oregon Clinic Gastroenterology-East, Portland
Usia 45 hingga 85 · Semua jenis kelamin · Diperbarui 14 Nov 2024 · NCT06612281

Uji klinis Kanker Kolorektal di kota lain

Studi lain di Portland

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.